UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

March 11, 2015

 

 

 

MULTICELL TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-10221   52-1412493
(State or other jurisdiction of incorporation)   (Commission  File Number)   (IRS Employer
Identification No.)

 

68 Cumberland Street, Suite 301

Woonsocket, Island 02895

(Address of principal executive offices, including zip code)

 

(401) 762-0045

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 5.07.Submission of Matters to a Vote of Security Holders.

 

MultiCell Technologies, Inc. (the “Company”) held its Annual Meeting of Stockholders on March 11, 2015, at the offices of Procopio, Cory, Hargreaves & Savitch LLP, One Del Mar, 12544 High Bluff Drive, Suite 300, San Diego, California 92130, to consider and vote on the matters listed below. The proposals are described in detail in the Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on December 12, 2014. The final voting results from the meeting are set forth below.

 

Proposal 1: Election of Directors

 

This proposal was to elect directors to serve for the ensuing year and until their successors are elected. Based on the following votes, the individuals named below were each elected to serve as directors until the Company’s next annual meeting of stockholders.

 

Name

 

Votes
For

 

Votes

Withheld

 

Broker
Non-Votes

             
W. Gerald Newmin  

760,163,035

 

139,542,195

   
Thomas A. Page  

771,163,049

 

128,542,181

   
Edward Sigmond  

767,610,977

 

132,094,253

   
Stephen Chang, Ph. D.  

831,730,289

 

67,974,941

   
Grant Miller  

771,173,508

 

128,531,722

   

 

Proposal 2: Ratification of Selection of Independent Auditors

 

The proposal ratifies the selection of Eide Bailly, LLP as the Company’s independent registered public accounting firm. The results of the voting included 2,792,701,382 votes for, 246,531,270 votes against, 102,535,500 votes abstained and no broker non-votes. The selection was ratified.

 

Proposal 3: Approval of the Certificate of Amendment of the Company’s Amended and Restated Certificate of Incorporation

 

The proposal was to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Restated Certificate”), to increase the number of authorized shares of the Company’s common stock to a total of 10.0 billion shares. The results of the voting included 2,271,617,094 votes for, 762,110,830 votes against, 108,040,228 votes abstained and no broker non-votes. The Certificate of Amendment to the Restated Certificate was approved.

 

Proposal 4: Approval of the Company’s 2014 Equity Incentive Plan

 

This proposal was to approve the Company’s 2014 Equity Incentive Plan (the “Plan”). The results of the voting included 569,733,952 votes for, 233,832,900 votes against, 96,138,378 votes abstained and no broker non-votes. The Plan was approved.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MULTICELL TECHNOLOGIES, INC.
   
   
  By:  /s/ W. Gerald Newmin
    W. Gerald Newmin
Chief Executive Officer, Chief Financial Officer

 

Date: March 13, 2015